Dimension-reduced outcome-weighted learning for estimating individualized treatment regimes in observational studies

• URL: http://arxiv.org/abs/2601.06782v1
• Date: Sun, 11 Jan 2026 05:38:08 GMT
• Title: Dimension-reduced outcome-weighted learning for estimating individualized treatment regimes in observational studies
• Authors: Sungtaek Son, Eardi Lila, Kwun Chuen Gary Chan,
• Abstract summary: Individualized treatment regimes (ITRs) aim to improve clinical outcomes by assigning treatment based on patient-specific characteristics.<n>We propose a novel sufficient dimension reduction approach that targets the contrast between potential outcomes and identifies a low-dimensional subspace.<n>We show that the proposed method achieves universal consistency, i.e., its risk converges to the Bayes risk, under mild regularity conditions.
• Score: 1.338174941551702
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Individualized treatment regimes (ITRs) aim to improve clinical outcomes by assigning treatment based on patient-specific characteristics. However, existing methods often struggle with high-dimensional covariates, limiting accuracy, interpretability, and real-world applicability. We propose a novel sufficient dimension reduction approach that directly targets the contrast between potential outcomes and identifies a low-dimensional subspace of the covariates capturing treatment effect heterogeneity. This reduced representation enables more accurate estimation of optimal ITRs through outcome-weighted learning. To accommodate observational data, our method incorporates kernel-based covariate balancing, allowing treatment assignment to depend on the full covariate set and avoiding the restrictive assumption that the subspace sufficient for modeling heterogeneous treatment effects is also sufficient for confounding adjustment. We show that the proposed method achieves universal consistency, i.e., its risk converges to the Bayes risk, under mild regularity conditions. We demonstrate its finite sample performance through simulations and an analysis of intensive care unit sepsis patient data to determine who should receive transthoracic echocardiography.

Related papers

• Overlap-weighted orthogonal meta-learner for treatment effect estimation over time [90.46786193198744]
  We introduce a novel overlap-weighted meta-learner for estimating heterogeneous treatment effects (HTEs)<n>Our WO-learner has the favorable property of Neyman-orthogonality, meaning that it is robust against misspecification in the nuisance functions.<n>We show that our WO-learner is fully model-agnostic and can be applied to any machine learning model.
  arXiv  Detail & Related papers  (2025-10-22T14:47:57Z)
• A Generative Framework for Causal Estimation via Importance-Weighted Diffusion Distillation [55.53426007439564]
  Estimating individualized treatment effects from observational data is a central challenge in causal inference.<n>In inverse probability weighting (IPW) is a well-established solution to this problem, but its integration into modern deep learning frameworks remains limited.<n>We propose Importance-Weighted Diffusion Distillation (IWDD), a novel generative framework that combines the pretraining of diffusion models with importance-weighted score distillation.
  arXiv  Detail & Related papers  (2025-05-16T17:00:52Z)
• Individualized Multi-Treatment Response Curves Estimation using RBF-net with Shared Neurons [1.1119247609126184]
  Our non-parametric modeling of the response curves relies on radial basis function (RBF)-nets with shared hidden neurons. Applying our proposed method to MIMIC data, we obtain several interesting findings related to the impact of different treatment strategies on the length of ICU stay and 12-hour SOFA score for sepsis patients who are home-discharged.
  arXiv  Detail & Related papers  (2024-01-29T21:13:01Z)
• Adversarially Balanced Representation for Continuous Treatment Effect Estimation [6.469020202994118]
  In this paper, we consider the more practical and challenging scenario in which the treatment is a continuous variable. We propose the adversarial counterfactual regression network (ACFR) that adversarially minimizes the representation imbalance in terms of KL divergence. Our experimental evaluation on semi-synthetic datasets demonstrates the empirical superiority of ACFR over a range of state-of-the-art methods.
  arXiv  Detail & Related papers  (2023-12-17T00:46:16Z)
• Flexible Nonparametric Inference for Causal Effects under the Front-Door Model [2.6900047294457683]
  We develop novel one-step and targeted minimum loss-based estimators for both the average treatment effect and the average treatment effect on the treated under front-door assumptions.<n>Our estimators are built on multiple parameterizations of the observed data distribution, including approaches that avoid mediator density entirely.<n>We show how these constraints can be leveraged to improve the efficiency of causal effect estimators.
  arXiv  Detail & Related papers  (2023-12-15T22:04:53Z)
• Estimating treatment effects from single-arm trials via latent-variable modeling [14.083487062917085]
  Single-arm trials, where all patients belong to the treatment group, can be a viable alternative but require access to an external control group. We propose an identifiable deep latent-variable model for this scenario. Our results show improved performance both for direct treatment effect estimation as well as for effect estimation via patient matching.
  arXiv  Detail & Related papers  (2023-11-06T10:12:54Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Assessment of Treatment Effect Estimators for Heavy-Tailed Data [70.72363097550483]
  A central obstacle in the objective assessment of treatment effect (TE) estimators in randomized control trials (RCTs) is the lack of ground truth (or validation set) to test their performance. We provide a novel cross-validation-like methodology to address this challenge. We evaluate our methodology across 709 RCTs implemented in the Amazon supply chain.
  arXiv  Detail & Related papers  (2021-12-14T17:53:01Z)
• Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score [59.75318183140857]
  Estimating causal effects from randomized experiments is central to clinical research. Most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control.
  arXiv  Detail & Related papers  (2020-12-17T21:10:10Z)
• Estimating heterogeneous survival treatment effect in observational data using machine learning [9.951103976634407]
  Methods for estimating heterogeneous treatment effect in observational data have largely focused on continuous or binary outcomes. Using flexible machine learning methods in the counterfactual framework is a promising approach to address challenges due to complex individual characteristics.
  arXiv  Detail & Related papers  (2020-08-17T01:02:14Z)
• Generalization Bounds and Representation Learning for Estimation of Potential Outcomes and Causal Effects [61.03579766573421]
  We study estimation of individual-level causal effects, such as a single patient's response to alternative medication. We devise representation learning algorithms that minimize our bound, by regularizing the representation's induced treatment group distance. We extend these algorithms to simultaneously learn a weighted representation to further reduce treatment group distances.
  arXiv  Detail & Related papers  (2020-01-21T10:16:33Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.